We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Gastroenterology

Journal Scan / Research · November 03, 2020

Vedolizumab Levels, Anti-Vedolizumab Antibodies, and Endoscopic Healing in Patients With IBD

Digestive Diseases and Sciences


Additional Info

Disclosure statements are available on the authors' profiles:

Digestive Diseases and Sciences
Association Between Vedolizumab Levels, Anti-Vedolizumab Antibodies, and Endoscopic Healing Index in a Large Population of Patients With Inflammatory Bowel Diseases
Dig. Dis. Sci. 2020 Oct 22;[EPub Ahead of Print], AJ Yarur, P Deepak, NV Casteele, R Battat, A Jain, L Okada, M Osterman, M Regueiro

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading